{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T20:19:17Z","timestamp":1789330757616,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.bcp.2024.116073","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T16:14:25Z","timestamp":1708532065000},"page":"116073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Apical papilla stem cell-derived exosomes regulate lipid metabolism and alleviate inflammation in the MCD-induced mouse NASH model"],"prefix":"10.1016","volume":"222","author":[{"given":"Yi-Fei","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ming","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duan-Qin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Qing","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bcp.2024.116073_b0005","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1089\/thy.2021.0621","article-title":"Thyroid hormone decreases hepatic steatosis, inflammation, and fibrosis in a dietary mouse model of nonalcoholic steatohepatitis","volume":"32","author":"Zhou","year":"2022","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.bcp.2024.116073_b0010","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","article-title":"Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116073_b0015","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/joim.13531","article-title":"Current treatment of non-alcoholic fatty liver disease","volume":"292","author":"Paternostro","year":"2022","journal-title":"J. Intern. Med."},{"issue":"7","key":"10.1016\/j.bcp.2024.116073_b0020","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"issue":"192","key":"10.1016\/j.bcp.2024.116073_b0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.freeradbiomed.2022.08.037","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate experimental non-alcoholic steatohepatitis via Nrf2\/NQO-1 pathway","volume":"1","author":"Kang","year":"2022","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.bcp.2024.116073_b0030","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for NAFLD\/NASH","volume":"53","author":"Sumida","year":"2018","journal-title":"J. Gastroenterol."},{"issue":"10290","key":"10.1016\/j.bcp.2024.116073_b0035","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bcp.2024.116073_b0040","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11684-018-0628-x","article-title":"Dental stem cell and dental tissue regeneration","volume":"13","author":"Zhai","year":"2019","journal-title":"Front. Med."},{"key":"10.1016\/j.bcp.2024.116073_b0045","article-title":"The biology, function, and biomedical applications of exosomes","volume":"Feb 7;367(6478):eaau6977","author":"Kalluri","year":"2020","journal-title":"Sci."},{"issue":"1","key":"10.1016\/j.bcp.2024.116073_b0050","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1186\/s13287-022-03201-7","article-title":"Human umbilical cord mesenchymal stromal cell-derived exosomes protect against MCD-induced NASH in a mouse model","volume":"13","author":"Shi","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bcp.2024.116073_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114040","article-title":"Mesenchymal stem cell-derived exosomes and non-coding RNAs: regulatory and therapeutic role in liver diseases","volume":"157","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2024.116073_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114624","article-title":"Upregulation of miR-96-5p by bone marrow mesenchymal stem cells and their exosomes alleviate non-alcoholic steatohepatitis: emphasis on caspase-2 signaling inhibition","volume":"190","author":"El-Derany","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116073_b0065","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s13287-021-02476-6","article-title":"Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis using amniotic epithelial cells","volume":"12","author":"Goonetilleke","year":"2021","journal-title":"Stem Cell Res. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2024.116073_b0070","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ymthe.2019.10.016","article-title":"HLSC-derived extracellular vesicles attenuate liver fibrosis and inflammation in a murine model of non-alcoholic steatohepatitis","volume":"28","author":"Bruno","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bcp.2024.116073_b0075","doi-asserted-by":"crossref","first-page":"2582080","DOI":"10.1155\/2017\/2582080","article-title":"The angiogenic potential of DPSCs and SCAPs in an in vivo model of dental pulp regeneration","volume":"2017","author":"Hilkens","year":"2017","journal-title":"Stem Cells Int."},{"issue":"273","key":"10.1016\/j.bcp.2024.116073_b0080","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2018.01.022","article-title":"Extracellular vesicle therapeutics for liver disease","volume":"10","author":"Borrelli","year":"2018","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.bcp.2024.116073_b0085","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2337\/db20-0619","article-title":"ETV5 regulates hepatic fatty acid metabolism through PPAR signaling pathway","volume":"70","author":"Mao","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2024.116073_b0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biochi.2016.12.019","article-title":"The role and regulation of the peroxisome proliferator activated receptor alpha in human liver","volume":"136","author":"Kersten","year":"2017","journal-title":"Biochimie"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2024.116073_b0095","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2006.02.028","article-title":"Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet","volume":"536","author":"Nagasawa","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2024.116073_b0100","doi-asserted-by":"crossref","first-page":"E730","DOI":"10.1152\/ajpendo.00225.2016","article-title":"Treatment of nonalcoholic fatty liver disease: role of AMPK","volume":"311","author":"Smith","year":"2016","journal-title":"Am. J. Phys. Endocrinol. Metab."},{"issue":"R1","key":"10.1016\/j.bcp.2024.116073_b0105","doi-asserted-by":"crossref","first-page":"R110","DOI":"10.1093\/hmg\/ddaa238","article-title":"Evolutionary forces in diabetes and hypertension pathogenesis in africans","volume":"30","author":"Meeks","year":"2021","journal-title":"Hum. Mol. Genet."},{"issue":"266","key":"10.1016\/j.bcp.2024.116073_b0110","article-title":"Aerobic training improves NAFLD markers and insulin resistance through AMPK-PPAR-\u03b1 signaling in obese mice","volume":"1","author":"Diniz","year":"2021","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.bcp.2024.116073_b0115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116073_b0120","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.jhep.2021.06.034","article-title":"Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality","volume":"75","author":"Simon","year":"2021","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116073_b0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.bcp.2024.116073_b0130","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1136\/gutjnl-2018-318146","article-title":"miRNAs and NAFLD: from pathophysiology to therapy","volume":"68","author":"Gjorgjieva","year":"2019","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.bcp.2024.116073_b0135","article-title":"Current and potential therapies targeting inflammation in NASH","volume":"3","author":"Albhaisi","year":"2021","journal-title":"Front Endocrinol (lausanne)."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2024.116073_b0140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/liv.14844","article-title":"New drugs for NASH","volume":"41","author":"Albhaisi","year":"2021","journal-title":"Liver Int."},{"issue":"7","key":"10.1016\/j.bcp.2024.116073_b0145","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1053\/j.gastro.2020.01.051","article-title":"Therapeutic landscape for NAFLD in 2020","volume":"158","author":"Neuschwander-Tetri","year":"2020","journal-title":"Gastroenterology"},{"issue":"2018","key":"10.1016\/j.bcp.2024.116073_b0150","first-page":"3212643","article-title":"Extracellular vesicles from amnion-derived mesenchymal stem cells ameliorate hepatic inflammation and fibrosis in rats","volume":"24","author":"Ohara","year":"2018","journal-title":"Stem Cells Int."},{"issue":"13","key":"10.1016\/j.bcp.2024.116073_b0155","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1242\/dev.134189","article-title":"Dental mesenchymal stem cells","volume":"143","author":"Sharpe","year":"2016","journal-title":"Development"},{"issue":"14","key":"10.1016\/j.bcp.2024.116073_b0160","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1021\/acsami.2c02278","article-title":"Dynamically bioresponsive DNA hydrogel incorporated with dual-functional stem cells from apical papilla-derived exosomes promotes diabetic bone regeneration","volume":"14","author":"Jing","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"21","key":"10.1016\/j.bcp.2024.116073_b0165","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1089\/scd.2015.0197","article-title":"Angiogenic potential and secretome of human apical papilla mesenchymal stem cells in various stress microenvironments","volume":"24","author":"Bakopoulou","year":"2015","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.bcp.2024.116073_b0170","article-title":"Modeling diet-induced NAFLD and NASH in rats","author":"Arreres","year":"2021","journal-title":"A Comprehensive Review. Biomedicines."},{"issue":"1","key":"10.1016\/j.bcp.2024.116073_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0959-9673.2006.00465.x","article-title":"Mouse models in non-alcoholic fatty liver disease and steatohepatitis research","volume":"87","author":"Anstee","year":"2006","journal-title":"Int. J. Exp. Pathol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116073_b0180","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0168-8278(03)00376-3","article-title":"Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis","volume":"39","author":"George","year":"2003","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.bcp.2024.116073_b0185","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrd.2015.3","article-title":"Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies","volume":"15","author":"Musso","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.bcp.2024.116073_b0190","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/liv.13634","article-title":"Dual PPAR\u03b1\/\u03b3 agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models","volume":"38","author":"Jain","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.bcp.2024.116073_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010037","article-title":"Anti-NASH drug development hitches a lift on PPAR agonism","author":"Boeckmans","year":"2019","journal-title":"Cells."},{"issue":"18","key":"10.1016\/j.bcp.2024.116073_b0200","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1016\/j.molcel.2021.08.015","article-title":"AMPK: restoring metabolic homeostasis over space and time","volume":"81","author":"Trefts","year":"2021","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bcp.2024.116073_b0205","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/j.gastro.2016.09.017","article-title":"Estrogen signals through peroxisome proliferator-activated receptor-\u03b3 coactivator 1\u03b1 to reduce oxidative damage associated with diet-induced fatty liver disease","volume":"152","author":"Besse-Patin","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bcp.2024.116073_b0210","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1053\/j.gastro.2020.06.031","article-title":"IRE1A stimulates hepatocyte-derived extracellular vesicles that promote inflammation in mice with steatohepatitis","volume":"159","author":"Dasgupta","year":"2020","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bcp.2024.116073_b0215","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/nu9040387","article-title":"Nonalcoholic fatty liver disease and insulin resistance: new insights and potential new treatments","volume":"9","author":"Kitade","year":"2017","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.bcp.2024.116073_b0220","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2337\/db17-0356","article-title":"Exosomes from adipose-derived stem cells attenuate adipose inflammation and obesity through polarizing M2 macrophages and beiging in white adipose tissue","volume":"67","author":"Zhao","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2024.116073_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105797","article-title":"Scoparone alleviates inflammation, apoptosis and fibrosis of non-alcoholic steatohepatitis by suppressing the TLR4\/NF-\u03baB signaling pathway in mice","volume":"75","author":"Liu","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116073_b0230","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1053\/j.gastro.2021.02.051","article-title":"Squalene epoxidase induces nonalcoholic steatohepatitis via binding to carbonic anhydrase III and is a therapeutic target","volume":"160","author":"Liu","year":"2021","journal-title":"Gastroenterology"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522400056X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522400056X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T19:56:39Z","timestamp":1711137399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522400056X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":46,"alternative-id":["S000629522400056X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116073","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apical papilla stem cell-derived exosomes regulate lipid metabolism and alleviate inflammation in the MCD-induced mouse NASH model","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116073"}}